LivaNova PLC (NASDAQ:LIVN) Receives $62.43 Consensus Target Price from Brokerages

Shares of LivaNova PLC (NASDAQ:LIVN) have been assigned an average rating of “Moderate Buy” from the nine research firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among analysts that have covered the stock in the last year is $65.6250.

Several research analysts have commented on LIVN shares. Robert W. Baird set a $75.00 price objective on shares of LivaNova in a report on Tuesday. Needham & Company LLC reissued a “buy” rating and issued a $64.00 price target on shares of LivaNova in a research note on Wednesday, September 3rd. The Goldman Sachs Group set a $55.00 price objective on LivaNova and gave the company a “neutral” rating in a research report on Wednesday, October 1st. Weiss Ratings reissued a “sell (d+)” rating on shares of LivaNova in a research report on Monday. Finally, KeyCorp assumed coverage on LivaNova in a research report on Friday. They set an “overweight” rating and a $81.00 price target on the stock.

LivaNova Stock Up 1.2%

NASDAQ LIVN opened at $62.82 on Friday. LivaNova has a 1 year low of $32.48 and a 1 year high of $65.57. The stock has a market capitalization of $3.43 billion, a PE ratio of -15.70 and a beta of 1.02. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.33 and a quick ratio of 1.12. The business’s 50-day moving average is $57.31 and its 200 day moving average is $52.21.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Arizona State Retirement System increased its stake in shares of LivaNova by 1.7% during the third quarter. Arizona State Retirement System now owns 16,129 shares of the company’s stock valued at $845,000 after purchasing an additional 274 shares in the last quarter. Bayforest Capital Ltd increased its position in LivaNova by 44.8% during the 3rd quarter. Bayforest Capital Ltd now owns 918 shares of the company’s stock valued at $48,000 after buying an additional 284 shares in the last quarter. State of Michigan Retirement System raised its stake in LivaNova by 2.3% during the second quarter. State of Michigan Retirement System now owns 13,111 shares of the company’s stock valued at $590,000 after buying an additional 300 shares during the last quarter. UMB Bank n.a. boosted its holdings in LivaNova by 63.0% in the third quarter. UMB Bank n.a. now owns 792 shares of the company’s stock worth $41,000 after acquiring an additional 306 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in shares of LivaNova by 182.5% in the 2nd quarter. GAMMA Investing LLC now owns 630 shares of the company’s stock worth $28,000 after purchasing an additional 407 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.